Every woman’s journey is unique. Understanding how the body prepares for ovulation is crucial to improving one's chances of conception. A follicular study, also known as follicular monitoring, helps ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new research study sponsored by Tempus and ...

Friedberg noted that chemotherapy combined with an antibody remains a recommended treatment for patients with advanced-stage ...

Patients with high-risk relapsed/refractory follicular lymphoma experienced statistically significant and clinically meaningful responses when treated with lisocabtagene maraleucel (liso-cel; Breyanzi ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Subcutaneous time-limited mosunetuzumab exhibited “highly encouraging efficacy” among patients with ...

Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik ® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to withdraw is based on ...

More than 138.3 million people are known to have contracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with over 2.9 million deaths. Jerusalem, in Israel, is a city that ...

Tempus Launches Its First Study With a Nonprofit Foundation Collaborator to Create Robust FL Dataset This multi-year study will enroll FL patients to generate a comprehensive, multi-omic dataset using ...